Molecular Diagnosis of Lung Cancer

Author:

Popovska Savelina L.1,Dineva Tereza B.2,Damyanova Polina D.2

Affiliation:

1. Department of Pathology , Medical University – Pleven , Bulgaria

2. Section of Molecular Pathology , University Scientific Research Laboratory , Medical University – Pleven , Bulgaria

Abstract

Summary Lung cancer is still the leading cancer-related cause of death with a high incidence rate in the whole world. Treatment options – surgery, radiotherapy, and chemotherapy, depending on the stage of the disease. During the last decade, many molecular alterations were discovered that led to impressive changes in treatment. Personalized approaches, including target therapies with specific inhibitor drugs, became a part of the standard therapies. This article reviews current molecular biomarkers used in clinical practice to treat lung cancer patients.

Publisher

Walter de Gruyter GmbH

Subject

General Medicine

Reference33 articles.

1. 1. Centers for Disease Control and Prevention. Compressed mortality file 1999-2011 [CD- ROM]. Atlanta: National Center for Health Statistics; 2014.

2. 2. National Oncological Hospital, Bulgarian National Cancer Resistry. Cancer Incidence in Bulgaria. Sofia: Paradigma; 2014, 170 p.

3. 3. Chilingirova N, Balabanski L, Toncheva D, Kurteva G, Damyanov D, Chilingirov P. Identifying the genetic landscape of squamous cell carcinoma (SCC) and adenosquamous carcinoma (ASC) of the lung using next- generation sequencing (NGS). Ann Oncol. 2015;26 Suppl: i1- i5.

4. 4. Chilingirova N, Balabanski L, Kurteva G, Toncheva D, Damyanov D, Chilingirov P. Detection of driver mutation heterogeneity in patients with non-small cell lung cancer (NSCLC) using next generation sequencing (NGS). EJC. 2015;51 Suppl 3:S612-S613.

5. 5. Chilingirova N, Balabanski L, Ivanov S, Vazharova R, Toncheva D, Kurteva G. Detection of extensive driver mutation heterogeneity in 5 Bulgarian patients with adenosquamous carcinoma of the lung. Eur J Hum Genet. 2015;23(1).

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. A Knowledge Construction on Lung Cancer through Deductive Learning Approach;2023 Second International Conference On Smart Technologies For Smart Nation (SmartTechCon);2023-08-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3